Immunomodulatory Protein ATYR1923 Disrupts an In-Vitro Model of Sarcoid Granuloma Formation

European Respiratory Society, 2021

« Treatment with ATYR1923 Reduces Biomarkers in COVID-19 Pneumonia

ATYR2810 an Anti-NRP2 Monoclonal Antibody Targets Tumor Associated Macrophages »

© 2007 - 2024 aTyr Pharma. Legal Privacy Policy